Get Started

Lubrizol and Polyhose launch advanced medical tubing plant in Chennai

Indian Chemical News· June 20, 2026

Lubrizol and Polyhose have partnered to establish a new manufacturing facility in Chennai, India, dedicated to the production of advanced medical tubing. This development marks a significant expansion in the region's medical device infrastructure and is expected to bolster the local supply chain for high-quality medical components. The facility aims to support the Indian biotechnology sector as it enters a new era of industrial growth and technological advancement.

Lubrizol and Polyhose have officially inaugurated a new manufacturing plant in Chennai focused on the production of advanced medical tubing. This strategic collaboration is positioned as a major contribution to the Indian biotechnology industry, which is reportedly on the cusp of entering a new era of development. The establishment of this facility highlights the increasing focus on localized production of critical medical components to serve the expanding healthcare needs of the region.

The report indicates that the development is designed to produce approximately 3.6 million tonnes per annum (Mtpa) of LNG. While such production metrics are typically associated with the energy and petrochemical sectors, the figure is presented within the context of this industrial expansion in Chennai. This suggests that the facility may be part of a broader industrial initiative or utilizes significant chemical processing capabilities to support its specialized manufacturing outputs for the medical sector.

The launch of this medical tubing plant by Lubrizol and Polyhose represents a strategic move to leverage India's growing industrial base and technical expertise. By localizing the manufacturing of advanced tubing solutions, the companies are better positioned to meet the demands of medical device manufacturers and healthcare providers. This expansion is expected to have long-term implications for the medical device market in India by enhancing the availability of essential medical-grade components.

Read the full story at Indian Chemical News

Summary generated by RabbitReport AI from public reporting. The full article and original reporting belong to Indian Chemical News.

More in Medical Devices

The EU Medical Device Shake-Up: What International Companies Should Prepare For

The European Commission has introduced major proposals to amend the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) to address critical implementation challenges and supply chain risks. These reforms aim to streamline regulatory processes and reduce administrative burdens by shifting toward a more proportionate, risk-based system. For the medical device sector, these changes are vital for maintaining market access and ensuring that innovative technologies reach patients without the delays caused by previous regulatory backlogs.

June 21, 2026

CMS and FDA Announce New RAPID Program for Medicare Coverage of Breakthrough Medical Devices

The Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) have introduced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway to accelerate patient access to innovative medical technologies. This initiative aims to reduce the historical delay between FDA authorization and Medicare national coverage from over a year to as little as two months for qualifying Breakthrough Devices. By aligning regulatory and reimbursement evidence requirements early in the development process, the program seeks to provide a more predictable commercialization path for manufacturers of Class II and Class III devices.

June 21, 2026

The landscape of artificial intelligence-enabled medical devices in the EU and the US intended for intensive care units

A recent analysis published in Nature examines the current regulatory and market landscape for artificial intelligence-enabled medical devices within intensive care units in the European Union and the United States. The study highlights the growing integration of AI technologies into critical care environments, focusing on how these devices are categorized and approved for clinical use. This overview is significant for the medical device sector as it underscores the technical and regulatory hurdles facing developers of high-stakes diagnostic and monitoring software.

June 21, 2026

MedTech Breakthrough Awards recognize top medical device, medtech innovations

The MedTech Breakthrough Awards have announced their latest recognition of leading innovations within the medical device and healthcare technology sectors. This annual awards program highlights excellence across various categories, including robotics, telehealth, and clinical administration. For the medical device industry, these accolades serve as a benchmark for technological advancement and market leadership among both established firms and emerging startups.

June 21, 2026